For the Inventor, By the Inventor

Enter assignee name

Bothell, WA, United States of America

Icos Corporation

USPTO Granted Patents = 164

% Expired Patents = 17.7

CIPO Patents = 4

EPO Patents = 14

Forward Citations = 2,910

Loading Chart...

Loading Chart...

107 inventors (with patents filed for the assignee):

Amy Oliver (36 out of 36 patents)

Edward A Kesicki (34 out of 45 patents)

W Michael Gallatin (31 out of 41 patents)

4. Kerry W Fowler (30 out of 45 patents)

5. Patrick W Gray (29 out of 33 patents)

6. Jennifer Anne Treiberg (24 out of 43 patents)

7. Joshua O Odingo (14 out of 17 patents)

8. Rosemay Vazeux (14 out of 15 patents)

9. Chanchal Sadhu (13 out of 13 patents)

10. C Gregory Sowell (13 out of 33 patents)

11. Larry W Tjoelker (13 out of 25 patents)

12. Danwen Huang (12 out of 16 patents)

13. Alain Claude-Marie Daugan (12 out of 26 patents)

14. Timothy J Martins (12 out of 12 patents)

15. Hua Chee Ooi (11 out of 11 patents)

Core Competencies:

Phosphatidylinositol

Inhibitors

Cyclic AMP

Chemokine

Quinazolinones

CHK1

PARP

Poly(ADP-Ribose)

Macrophage

Thiazole

Antibodies

Urea Derivatives

164 patents: Sort by Forward Citations

1. 10906907 - Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof (2021-02-02),

2. 10695349 - Inhibitors of human phosphatidylinositol 3-kinase delta (2020-06-30),

3. 10398695 - Inhibitors of human phosphatidylinositol 3-kinase delta (2019-09-03),

4. 10336756 - (S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta (2019-07-02),

5. 10010550 - Inhibitors of human phosphatidylinositol 3-kinase delta (2018-07-03),

6. 9487772 - Inhibitors of human phosphatidylinositol 3-kinase delta (2016-11-08),

7. 9149477 - 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta (2015-10-06),

8. 8993583 - 5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta (2015-03-31),

9. 8980901 - 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta (2015-03-17),

10. 8779131 - 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta (2014-07-15),

11. 8653077 - Inhibitors of human phosphatidylinositol 3-kinase delta (2014-02-18),

12. 8637533 - Inhibitors of human phosphatidylinositol 3-kinase delta (2014-01-28),

13. 8623881 - Inhibitors of human phosphatidylinositol 3-kinase delta (2014-01-07),

14. RE44638 - Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta (2013-12-09),

15. 8586597 - 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta (2013-11-19),

Icos Corporation, based in Bothell, WA, specializes in the development of innovative therapeutic solutions focusing on phosphatidylinositol inhibitors. The company is engaged in advanced research surrounding key biological pathways, including cyclic AMP modulation and chemokine signaling. Icos is recognized for its work with quinazolinones and its contributions to the understanding of CHK1 and PARP mechanisms, which are pivotal in cancer treatment and other therapeutic areas. Its expertise positions Icos at the forefront of biopharmaceutical advancements.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Icos Corporation

164 Patents

#2 in Bothell, WA

#45 in Washington

#2,419 in US

#5,032 in the World

Bothell, WA, United States of America

Icos Corporation

Forward Citations = 2,910

107 inventors:

Amy Oliver (36 out of 36 patents)

Edward A Kesicki (34 out of 45 patents)

W Michael Gallatin (31 out of 41 patents)

4. Kerry W Fowler (30 out of 45 patents)

5. Patrick W Gray (29 out of 33 patents)

Please report any incorrect information to [email protected]

Loading…